🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a first-in-human trial proposed to test CD19-specific CAR-T cells w...
Status
Unknown
Location
Xijing Hospital
Start Date
2019-08
Trial ID
NCT04037566
Treatments Being Tested
This is a two-part Phase 1/2 dose escalation and dose expansion study of an...
Status
Completed
Location
Research Facility
Start Date
2017-09-07
Trial ID
NCT02963831
Treatments Being Tested
Chimeric antigen receptor (CAR)-modified T cells can mediate long-term dura...
Status
Unknown
Location
Sanbo Brain Hospital Capital Medical University
Start Date
2016-07
Trial ID
NCT02844062
Treatments Being Tested
Retinoblastoma is a childhood cancer which affects the retina of the eye. T...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2005-04-07
Trial ID
NCT00186888
Based on data supporting the use of cyclophosphamide and etoposide both as ...
Status
Completed
Location
Central Jersey Oncology Center
Start Date
2005-05
Trial ID
NCT00176605
Treatments Being Tested
This is a phase ll study of participants with untreated diffuse large B Cel...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2025-01-24
Trial ID
NCT06050694
Treatments Being Tested
Severe congenital neutropenia (SCN) is a group of primary immunodeficiencie...
Status
Unknown
Location
HSCT department
Start Date
2021-04-14
Trial ID
NCT04844177
Treatments Being Tested
RATIONALE: Studying samples of blood and tissue from patients with cancer i...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00933127
Treatments Being Tested
This study is determining whether the addition of cyclophosphamide to pomal...
Status
Active Not Recruiting
Location
Belfast Health & Social Care Trust
Start Date
2016-03
Trial ID
NCT02406222
Treatments Being Tested
TAC01-HER2 is a novel cell therapy that consists of genetically engineered ...
Status
Terminated
Location
Lurie Cancer Center - Northwestern University
Start Date
2021-04-19
Trial ID
NCT04727151
Treatments Being Tested